D
Lineage Cell Therapeutics, Inc. LCTX
$1.25 $0.086.84% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -428.89% 36.73% 31.46% 57.33% -10.15%
Total Depreciation and Amortization 20.42% -6.29% -13.71% -19.89% -16.47%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1,648.77% -142.50% -7.81% -59.82% -18.12%
Change in Net Operating Assets -112.27% 71.15% -145.88% -2,570.50% 64.28%
Cash from Operations -7.01% 15.51% -5.43% -14.89% 17.42%
Capital Expenditure 72.00% -155.26% -301.10% 19.42% 80.47%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 100.00% -- -69.49% 76.91% -145.03%
Cash from Investing 99.84% 5,107.89% -72.95% 83.22% -145.89%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% -7.69% -7.69% -8.33% 12.50%
Issuance of Common Stock -- -62.32% -- -98.82% -97.95%
Repurchase of Common Stock -- 34.78% 100.00% -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -129.15% 100.00% --
Cash from Financing -392.38% -64.03% 167,284.62% -100.37% -98.13%
Foreign Exchange rate Adjustments 432.95% -4.29% -91.13% 111.18% 4.35%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 60.10% -75.55% 352.10% 23.86% -175.71%